Medicinal composition for treating coronary heart disease and preparation process thereof

Abstract

The invention discloses a drug combination for remedying the coronary heart disease and the preparation method and quality control method of the drug combination. The drug combination consists of an extract of a milkvetch root and the extract of a red salvia root. The preparation method of the drug combination is that the extract of the milkvetch root and the extract of the red salvia root are dissolved in the water for injection; the pH value is regulated; active carbon is added into the solution to be boiled, sealed, frozen, filtered; the filtrate is added with the active carbon to be boiled and filtered; the filtrate is respectively filtered by a microporous filtering film again; the water for injection is added into the filtrate for filling, freezing and drying to obtain the drug combination. The efficacy of drug combination is to benefit qi and activate blood circulation, and the drug combination has obvious effect of remedying the coronary heart disease and especially the angina, caused by the coronary heart disease.

Description

technical field [0001] The invention relates to a pharmaceutical composition, a preparation method and a quality control method thereof, in particular to a pharmaceutical composition for treating coronary heart disease, a preparation method and a quality control method thereof. Background technique [0002] With the aging of the social population and the influence of factors such as modern diet and environment, the incidence of cardiovascular diseases such as coronary heart disease and angina pectoris continues to rise, and the research on cardiovascular disease drugs has also been receiving much attention. At present, there are a large number of drugs for the treatment and prevention of coronary heart disease in clinical medicine, and the commonly used drugs mainly include: drugs for dilating blood vessels to improve symptoms, including nitrates, such as nitroglycerin, etc., calcium antagonists, such as nifedipine, β- Receptor blockers, such as propranolol, etc., anti-plate...

AI Technical Summary

Problems solved by technology

Deficiency in origin is mainly qi deficiency, and excess in superficiality is mainly blood stasis. Therefore, in the treatment, it should be based on nourishing qi and activating blood circulation. There are many medicines that use invigorating qi and activating blood circulation as the main treatment method in the current oral preparations, and they have also achieved good results. curative effect, but there is no medicine for nourishing qi and promoting blood circulation in solid preparations and injections that are more suitable for the treatment of coronary heart disease.

Images